173 Results for "

Exatecan Mesylate

" in MedChemExpress (MCE) Product Catalog:
Products (173)

173 Results for "Exatecan Mesylate" in MCE Product Catalog:

23
23 Publications Verification
Cat. No.: HY-13631A
CAS No.: 169869-90-3
Purity:  99.97%
Synonyms: DX8951f
Research Areas:  

Cancer

Exatecan mesylate (DX8951f) is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL). Exatecan mesylate can be used in cancer research.
23
23 Publications Verification
Cat. No.: HY-13631
CAS No.: 171335-80-1
Purity:  99.69%
Synonyms: DX-8951
Research Areas:  

Cancer

Exatecan (DX-8951) is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL), and can be used in cancer research.
14
14 Cited Publications
Cat. No.: HY-13631D
CAS No.: 1599440-33-1
Purity:  99.30%
Synonyms: Exatecan derivative for ADC
Research Areas:  

Cancer

DXd (Exatecan derivative for ADC) is a potent DNA topoisomerase I inhibitor, with an IC50 of 0.31 μM, used as a conjugated drug of HER2-targeting ADC (DS-8201a).
6
6 Cited Publications
Cat. No.: HY-114233
CAS No.: 1600418-29-8
Purity:  99.71%
Synonyms: MC-GGFG-DX8951
Research Areas:  

Cancer

MC-GGFG-Exatecan (MC-GGFG-DX8951) is a agent-linker conjugate for ADC. MC-GGFG-Exatecan is a DX8951 (a DNA topoisomerase I inhibitor) derivative with protease cleavable MC-GGFG linker. MC-GGFG-Exatecan shows antitumor activity and can be used to prepare DX8951 antibody conjugate (ADC) .
2
2 Cited Publications
Cat. No.: HY-145929
CAS No.: 2504068-28-2
Purity:  99.57%
Synonyms: MC-Val-Cit-PAB-DX8951
Research Areas:  

Cancer

MC-Val-Cit-PAB-Exatecan (MC-Val-Cit-PAB-DX8951) is a agent-linker conjugate for ADC. MC-Val-Cit-PAB-Exatecan is composed of a DNA topoisomerase I DX-8951 (HY-13631) and a cathepsin cleavable ADC linker.
1
1 Cited Publications
Cat. No.: HY-147270
CAS No.: 2680543-57-9
Purity:  99.58%
Research Areas:  

Cancer

MC-VA-PAB-Exatecan is a agent-linker conjugate for ADC. MC-VA-PAB-Exatecan contains the ADC linker (peptide MC-VA-PAB) and a DNA topoisomerase I inhibitor Exatecan (HY-13631). MC-VA-PAB-Exatecan synthesized ADC shows good antitumor activity .
1
1 Cited Publications
Cat. No.: HY-147095
CAS No.: 2845164-91-0
Purity:  99.90%
Research Areas:  

Cancer

Val-Ala-PABC-Exatecan is a Drug-Linker Conjugates for ADC, consiting of a cleavable Tesirine linker (Val-Ala-PABC) and Exatecan (HY-13631) (topoisomerase I inhibitor). Val-Ala-PABC-Exatecan can be used for ADC molecues synthesis, such as Mal-PEGn-amide-va-Exatecan .
1
1 Cited Publications
Cat. No.: HY-153069
CAS No.: 251459-32-2
Purity:  99.71%
Research Areas:  

Cancer

GGFG-PAB-Exatecan consists of an ADC toxin Exatecan (HY-13631) and a linker GGFG-PAB, and can be used as a drug-linker conjugate for the synthesis of ADC molecules .
1
1 Cited Publications
Cat. No.: HY-147095A
CAS No.: 2928571-45-1
Purity:  98.39%
Research Areas:  

Cancer

Val-Ala-PABC-Exatecan trifluoroacetate is a Drug-Linker Conjugates for ADC, consiting of a cleavable Tesirine linker (Val-Ala-PABC) and Exatecan (topoisomerase I inhibitor, HY-13631). Val-Ala-PABC-Exatecan trifluoroacetate can be used for ADC molecues synthesis, such as Mal-PEGn-amide-va-Exatecan .
Cat. No.: HY-13631AS
CAS No.: 2819276-88-3
Purity:  99.82%
Synonyms: DX8951f-d5; Deuterated labeled Exatecan Mesylate
Exatecan-d5 (DX8951f-d5) mesylate is deuterium labeled Exatecan mesylate (HY-13631A). Exatecan mesylate is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL). Exatecan mesylate can be used in cancer research .
Cat. No.: HY-153179
CAS No.: 2763252-25-9
Purity:  99.82%
Research Areas:  

Cancer

Mal-Gly-PAB-Exatecan-D-glucuronic acid can be used for Antibody-Drug Conjugates (ADCs) synthesis. Mal-Gly-PAB-Exatecan-D-glucuronic acid can be used for research of tumor research and diagnosis .
Cat. No.: HY-42487
CAS No.: 110351-94-5
Research Areas:  

Cancer

Exatecan Intermediate 1 (compound 6) is an intermediate of Exatecan (HY-13631). Exatecan is a DNA topoisomerase I inhibitor with anticancer effects .
Cat. No.: HY-13631R
CAS No.: 171335-80-1
Synonyms: DX-8951 (Standard)
Research Areas:  

Cancer

Exatecan (Standard) is the analytical standard of Exatecan. This product is intended for research and analytical applications. Exatecan (DX-8951) is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL), and can be used in cancer research.
Cat. No.: HY-145397
CAS No.: 2495742-21-5
Purity:  99.93%
Synonyms: AZ14170132
Research Areas:  

Cancer

(4-NH2)-Exatecan (compound A), a topoisomerase inhibitor, is a derivative of Exatecan. (4-NH2)-Exatecan can be used in the synthesis of antibody-drug conjugates (ADCs) .
Cat. No.: HY-160788
CAS No.: 3025107-83-6
Research Areas:  

Cancer

DBCO-β-Glu-PEG12-Exatecan (Compound 107) is an inhibitor for topoisomerase I. DBCO-β-Glu-PEG12-Exatecan can be used as a Drug-Linker Conjugate for ADC molecule .
Cat. No.: HY-13631AG
CAS No.: 169869-90-3
Synonyms: DX8951f (GMP)
Exatecan mesylate (DX8951f ) GMP is a GMP-class Exatecan (HY-13631). Exatecan is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL), and can be used in cancer research .
Cat. No.: HY-156617A
CAS No.: 2414254-37-6
Purity:  99.75%
Synonyms: SHR169265
Research Areas:  

Cancer

(αR)-Cyclopropaneacetamide-Exatecan (SHR169265) is a DNA Topoisomerase I inhibitor with enhanced membrane permeability (with an IC50 of 1.34 μM against the human DNA Topoisomerase I). (αR)-Cyclopropaneacetamide-Exatecan exerts cytotoxic effects by inhibiting the enzymatic activity of Topoisomerase I, and this anticancer effect is independent of the expression level of HER2. (αR)-Cyclopropaneacetamide-Exatecan is an ADC Cytotoxin derived from Exatecan (HY-13631), which can be used in research related to advanced cancers such as breast cancer, gastric cancer, colorectal cancer and non-small cell lung cancer .
Cat. No.: HY-W021377
CAS No.: 182182-31-6
Research Areas:  

Cancer

Exatecan Intermediate 2 (Compound B) is an intermediate of Exatecan (DX-8951, HY-13631). Exatecan is an anticancer agent belonging to the class of camptothecin analogs. Exatecan interferes with the proliferation and division of tumor cells by interacting with DNA, thereby inhibiting tumor growth. Exatecan is primarily used for research of a variety of cancers including ovarian, lung and breast cancers .
Cat. No.: HY-44369
CAS No.: 143655-58-7
Research Areas:  

Cancer

Exatecan Intermediate 6 is the intermediate of Exatecan (HY-13631) And Exatecan (DX-8951) is a DNA topoisomerase I inhibitor with an IC50 value of 2.2 μM (0.975 μg/mL) that can be used in cancer research. Exatecan Intermediate 6 can be used to synthesize Antibody-Drug Conjugates (ADCs).
Cat. No.: HY-128995AS
Purity:  95.08%
Synonyms: Glycyl-DX-8951-d5 hydrochloride; Exatecan analog 2-d5 hydrochloride
Glycyl-Exatecan-d5 (Glycyl-DX-8951-d5) hydrochloride is deuterium labeled Glycyl-Exatecan (HY-128995A). Glycyl-Exatecan (Glycyl-DX-8951), a derivative of Exatecan (HY-13631), is an anticancer agent. Glycyl-Exatecan has significantly antitumor activity. Glycyl-Exatecan can be used for cancers like solid tumors research.